Peptide fructose and protein conjugate with the same
View Patent ↗It is intended to provide an antibody specific to HbA1c, antibody-producing cells capable of supplying the antibody in a stable state in the future, and a method of constructing the antibody-producing cells without any probability factors, and a method which comprises fusing mouse spleen cells, which have been sensitized with an immunogen composed of a compound containing the following structural formula (I) and a binding protein, with a myeloma-origin cell line, obtaining monoclonal antibody-producing cells by cloning, and then purifying and acquiring the monoclonal antibody produced by these cells into the culture supernatant
1. A protein conjugate, comprising a peptide fructose linked with a protein, and the peptide fructose compound is represented by formula (I) below:
wherein R1 represents a cysteine residue, the R1 is linked to the carboxy-terminus of R2 at (b) with a covalent bond, the R2 contains two or more amino acids derived from the amino acid sequence of HbA1 or an amino acid analog functionally equivalent to the amino acids, and the R2 is linked to the fructose at the amino-terminus thereof, and the protein is CGG, wherein the peptide fructose compound is linked to CGG at R1.
2. A protein conjugate according to claim 1 , wherein the R2 contains at least a peptide represented by formula (II) below:
3. A protein conjugate according to claim 1 , wherein the R2 contains at least a peptide represented by formula (III) below:
4. A protein conjugate according to claim 1 , wherein the covalent bond at (b) is a peptide bond.
5. An antiserum, produced in the blood of an animal by injecting a protein conjugate according to claim 1 into said animal.
6. An antibody, isolated from an antiserum according to claim 5 .
7. An isolated monoclonal antibody-producing cell, wherein the monoclonal antibody-producing cell is obtained by fusing a spleen cell of a mouse sensitized with a protein conjugate according to claim 1 , with a myeloma-derived cell, and cloning a fused cell, and the monoclonal antibody-producing cell produces a monoclonal antibody capable of specifically binding to human hemoglobin A1c.
8. The monoclonal antibody-producing cell according to claim 7 , designated as deposit number FERM BP-7637 or FERM BP-7636.
9. A method of producing a monoclonal antibody-producing cell capable of producing a monoclonal antibody capable of specifically binding to human hemoglobin A1c, the method comprising the steps of:
a) sensitizing a mouse with a protein conjugate according to claim 1 ; and
b) isolating a spleen cell from the sensitized mouse, and fusing the spleen cell with a myeloma-derived cell.
10. A monoclonal antibody, produced by a monoclonal antibody-producing cell according to claim 7 , which specifically binds to human hemoglobin A1c.
11. A monoclonal antibody produced by the monoclonal antibody-producing cell sensitized with a protein conjugate according to claim 1 , wherein the binding constant to human hemoglobin A1c thereof is 10 4 or more.